Hwang, NJ
Charles G. Hwang, Ridgewood, NJ US
Patent application number | Description | Published |
---|---|---|
20080269697 | Luer Connector Assembly - A luer connector assembly is provided for enhancing the frictional engagement between medical devices such as syringes and needle assemblies. The assembly needle includes a female luer fitting having a passageway and a relatively soft, resilient member bounding the passageway. The passageway is also bounded by the body of the fitting, which is harder than the soft, resilient member. A male luer fitting inserted into the passageway engages both the soft, resilient member and the body of the female luer fitting. A method of manufacturing such a connector assembly is further provided. A first material is injected into a mold to form the body of a female luer fitting, the fitting including a passageway and a recess extending into the body. A second material is then injected such that it extends into the recess and bounds the passageway. The second material, when cool, is softer than the first material. | 10-30-2008 |
20090093771 | Single-Handedly Actuatable Shield - A needle shield is provided for a medical device having a needle cannula. The needle shield includes a guard that is slidably movable along the needle cannula from a proximal position where the tip of the needle cannula is exposed to a distal position where the tip of the needle cannula is shielded. A hinged arm connects the guard to the proximal end of the needle cannula. The hinged arm can be collapsed upon itself, such that the guard is adjacent to the proximal end of the needle cannula. The hinged arm can be extended to cause the guard to move distally along the needle cannula and into a position for shielding the tip of the needle cannula. Structure is provided to prevent excessive additional rotation of the hinged elements of the hinged guard after the tip of the needle cannula is shielded. | 04-09-2009 |
20090259201 | Flash Activated Passive Shielding Needle Assembly - A safety needle device includes a housing including a passageway with a needle cannula extending therefrom. A shielding member is movable between a first position in which a puncture tip of the needle cannula is exposed therefrom and a second position in which the puncture tip of the needle cannula is encompassed therein. The shielding member is maintained in the first position against a biasing force which biases the shielding member toward the second position. A fluid and/or temperature activation material, such as a hydrogel or a compressed sponge, is associated with the shielding member and is adapted to deform upon contact with a fluid medium and/or a certain temperature or temperature range. Fluid flowing through the needle cannula, such as blood flow during a blood collection procedure, causes the activation material to deform, such as through expansion, thereby releasing the shielding member from the first position and allowing the drive member to bias the shielding member toward the second position. | 10-15-2009 |
Cheng Hwang, New Milford, NJ US
Patent application number | Description | Published |
---|---|---|
20130064905 | Method for Enhancing the Growth and Fullness of Hair - New fibroblast growth factor receptor 1 (FGFR1) inhibitors have been identified which are useful for promoting the retention and/or growth of keratin fibers, such as hair of the scalp, hair of the face (moustache, beard, etc.), eyebrows, eyelashes, and the like. The FGFR1 inhibitors may be formulated in effective amounts in a variety of cosmetic and personal care products. | 03-14-2013 |
20130102606 | Compositions and Methods for Stimulating Collagen Synthesis in the Skin - Cosmetic compositions comprising substituted carbamoyl heterocyclic analogs and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The substituted carbamoyl heterocyclic analogs are believed to have modulatory activity against one or more biochemical pathways implicated in skin aging. | 04-25-2013 |
Cheng Shine Hwang, New Milford, NJ US
Patent application number | Description | Published |
---|---|---|
20100158828 | Topical Compositions Containing CIS-6-Nonenol and its Derivatives and Methods for Treating Skin - Cosmetic compositions comprising cis-6-nonenol and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. Cis-6-nonenol is believed to have modulatory activity against at least one biochemical pathway implicated in skin aging. | 06-24-2010 |
20110251291 | Topical Compositions Containing CIS-6-Nonenol and its Derivatives and Methods for Treating Skin - Cosmetic compositions comprising cis-6-nonenol and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. Cis-6-nonenol is believed to have modulatory activity against at least one biochemical pathway implicated in skin aging. | 10-13-2011 |
Dah-Min David Hwang, Holmdel, NJ US
Patent application number | Description | Published |
---|---|---|
20120087665 | METHOD AND APPARATUS FOR PROVIDING A ROUTE RECOMMENDATION - A method and apparatus for providing a route recommendation are disclosed. For example, the method obtains network topology information, wherein the network topology information comprises a plurality of underlying subnetwork types for a network. The method creates a cost model for the network, and receives a request from a user for a connection to be supported by the network. The method provides the route recommendation for supporting the connection by applying the cost model. | 04-12-2012 |
Donna Hui-Ing Hwang, Leonia, NJ US
Patent application number | Description | Published |
---|---|---|
20080267889 | Cosmetic Cooling Composition - The invention relates to a cosmetic composition having a cooling effect, particularly a clear gel or a spray. The composition has a long-lasting cooling effect of about 8 hours and comprises a cooling complex consisting of 0.05-0.15% Menthyl Lactate, 0.1-0.2% Menthyl PCA and 0.05-0.2% Ethyl Menthane Carboxamide. | 10-30-2008 |
20090087396 | Sweat-Absorbing Cosmetic Product and Method for the Production Thereof - The invention relates to a preferably water-free sweat-absorbing cosmetic product, e.g. an antiperspirant, containing a base formulation and a sweat-absorbing complex. The invention also relates to a method for the production of said complex and said cosmetic product. | 04-02-2009 |
20090220555 | Sweat-Absorbing Cosmetic Product and Method for the Production Thereof - The invention relates to a—in particular—hydrous, sweat-absorbing cosmetic product, e.g. a deodorant, containing a sweat-absorbing complex. The invention also relates to a method for the production of said complex and said cosmetic product. | 09-03-2009 |
Hans Hwang, Watchung, NJ US
Patent application number | Description | Published |
---|---|---|
20140038550 | SERVICE DELIVERY PLATFORM AND DEVELOPMENT OF NEW CLIENT BUSINESS MODELS - The present invention relates to systems and methods for delivering telecommunications services to customers. The systems and methods allow for the rapid creation and deployment of new telecommunications services, and the bundling of multiple services into service packages that can be sold together as a single product. Based on the systems and methods, targeted service packages may be developed and marketed toward business customers in specific industries. The systems and method provide opportunities for new business arrangements between telecommunications service providers and smaller third party providers. The new business arrangements provide access to a much wider customer pool for the third | 02-06-2014 |
Herng Shinn Hwang, Livingston, NJ US
Patent application number | Description | Published |
---|---|---|
20080302104 | Catalytic Engine - A catalytic engine comprises a catalytic reformer and a turbine, and it employs the process steps of introducing a reactant mixture of fuel, air, water and recycled exhaust gas into a reaction zone, reacting said fuel mixture over oxidation catalysts in the reaction zone by adjusting the CO | 12-11-2008 |
20090035192 | Catalytic EGR oxidizer for IC engines and gas turbines - By using catalytic partial oxidation or autothermal reforming process, a catalytic oxidizer installed in the engine's Exhaust Gas Recycle (EGR) line can be used to produce from fossil fuels or bio-fuels a reformate gas containing H | 02-05-2009 |
20130312384 | Flex-Fuel Hydrogen Generator for IC Engines and Gas Turbines - An on-board Flex-Fuel H | 11-28-2013 |
Hiu-Ing Donna Hwang, Leonia, NJ US
Patent application number | Description | Published |
---|---|---|
20150342845 | COSMETIC COMPOSITIONS WITH ENHANCED COLOR RETENTION FOR IMPROVED SKIN APPEARANCE - A cosmetic composition with enhanced water resistance, color intensity and color retention after exposure to water is disclosed herein. The composition comprises a water dispersible film former component, a skin adhesion promoter component, a color enhancer component, and one or more colorants. The synergy of the components contributes to the improved attributes of the composition. | 12-03-2015 |
Hui-Ing Donna Hwang, Leonia, NJ US
Patent application number | Description | Published |
---|---|---|
20130309182 | VISCOUS ALCOHOL-CONTAINING SUNSCREEN COMPOSITIONS - The present disclosure provides a composition that maintains a high and desirable viscosity while having a high amount of alcohol. Suitable thickeners and gelling agents are mixed with the alcohol to achieve this effect. An emulsion stabilizer can also be added. These components can also be combined with a sunscreen. The resulting composition provides benefits such as cooling and desirable skin feel, but is still easily spreadable and viscous enough to function effectively as a sunscreen. | 11-21-2013 |
James Cheng-Min Hwang, Princeton Junction, NJ US
Patent application number | Description | Published |
---|---|---|
20100085120 | ADAPTIVE BIAS TECHNIQUE FOR FIELD EFFECT TRANSISTOR - A power amplifier includes a LDMOS transistor having a source, a drain, a control gate and a shielding electrode positioned between the control gate and the drain, and means for adaptively biasing the drain and shielding electrode power information for a RF signal. | 04-08-2010 |
James Y. Hwang, Jersey City, NJ US
Patent application number | Description | Published |
---|---|---|
20130286272 | CAMERA DATA MANAGEMENT AND USER INTERFACE APPARATUSES, SYSTEMS, AND METHODS - In certain embodiments, a live camera sensor view and an image manager pane are displayed together in a graphical user interface (“GUI”), and the image manager pane includes a visual representation of a previously captured camera image and a visual indication of a user input to be provided by a user to cause an active input mode to directly toggle between the image manager pane and the live camera sensor view. In certain embodiments, a camera image stored locally by a device is published by the device, over a network, to a content distribution subsystem configured to automatically distribute the camera image to one or more predefined destinations. The content distribution subsystem automatically distributes the camera image to the one or more predefined destinations. | 10-31-2013 |
20140280599 | CAMERA DATA MANAGEMENT AND USER INTERFACE APPARATUSES, SYSTEMS, AND METHODS - In certain embodiments, a camera image stored locally by a device is published by the device, over a network, to a content distribution subsystem configured to automatically distribute the camera image to one or more predefined destinations in accordance with a distribution service. The content distribution subsystem automatically distributes the published camera image to the one or more predefined destinations in accordance with the distribution service. | 09-18-2014 |
20140331178 | DIGITAL IMAGE TAGGING APPARATUSES, SYSTEMS, AND METHODS - In an exemplary embodiment, user input is received, a selected portion of a digital image is identified based on the user input, a data instance is selected, and a tag is applied to the selected portion of the digital image. The applied tag provides an association between the selected portion of the digital image and the data instance. In certain examples, a visual indicator representative of the tag is provided for display together with the tagged digital image. | 11-06-2014 |
20150237593 | POWER CONSERVATION ON USER DEVICES HAVING LOCATION IDENTIFICATION HARDWARE - A user device may detect, using a first radio associated with the user device, a presence of a location reference device; and determine a location associated with the user device. When determining the location associated with the user device, the user device is to receive location information from the location reference device, via the first, and refrain, based on detecting the presence of the location reference device, from determining the location using a second radio associated with the user device while the user device is within a communication range of the location reference device. | 08-20-2015 |
Jinseok Hwang, Palisade Park, NJ US
Patent application number | Description | Published |
---|---|---|
20120042433 | Zipper Arrangement - A zipper arrangement is configured to fasten a first fabric portion to a second fabric portion. The zipper arrangement includes a plurality of first zipper elements positioned along the first fabric portion and a plurality of second zipper elements positioned along the second fabric portion. A zipper closure includes a first closure member releasably coupled to a second closure member. The first closure member is positioned on a mid-portion of the first fabric portion and the second closure member is positioned on a mid-portion of the second fabric portion. A first slider is positioned on one side of the zipper closure and a second slider positioned on an opposite side of the zipper closure. When provided on a garment, the zipper arrangement may be used in association with a method for fastening a first garment portion to a second garment portion by moving the sliders in opposing directions. | 02-23-2012 |
20120117765 | ZIPPER ARRANGEMENT WITH FUNNEL GRIP - A zipper arrangement comprises a first side with a first plurality of zipper elements and a second side with a second plurality of zipper elements. A slider is moveably positioned on the first side and an insertion pin assembly is positioned on the second side. The insertion pin assembly includes a mouth defined between an inner jaw and an outer jaw and an insertion pin positioned within the mouth. The mouth is configured to receive the slider and the insertion pin is configured for insertion into the slider. | 05-17-2012 |
20120117766 | ZIPPER ARRANGEMENT WITH WHEELED SLIDER - A zipper arrangement comprises a plurality of zipper elements with a slider moveably positioned on the plurality of zipper elements. At least one wheel is rotatably positioned on the slider and configured to engage the plurality of zipper elements. The at least one wheel may include a first wheel configured to engage a first plurality of zipper elements and a second wheel configured to engage a second plurality of zipper elements within a slider. The slider may be generally triangular or trapezoidal in shape. Accordingly, the slider and includes a first end configured to pass disengaged zipper elements and a second end configured pass engaged zipper elements, wherein the second end is wider than the first end. The slider also includes a window configured to display at least a portion of the first wheel and the second wheel. | 05-17-2012 |
20130269085 | Zipper Arrangement - A zipper arrangement is configured to fasten a first fabric portion to a second fabric portion. The zipper arrangement includes a plurality of first zipper elements positioned along the first fabric portion and a plurality of second zipper elements positioned along the second fabric portion. A zipper closure includes a first closure member releasably coupled to a second closure member. The first closure member is positioned on a mid-portion of the first fabric portion and the second closure member is positioned on a mid-portion of the second fabric portion. A first slider is positioned on one side of the zipper closure and a second slider is positioned on an opposite side of the zipper closure. The zipper arrangement may be used to fasten and unfasten a front right garment portion and a front left garment portion by moving the sliders in opposing directions. | 10-17-2013 |
20140289928 | Zipper Arrangement - A zipper arrangement is configured to fasten a first fabric portion to a second fabric portion. The zipper arrangement includes a plurality of first zipper elements positioned along the first fabric portion and a plurality of second zipper elements positioned along the second fabric portion. A zipper closure includes a first closure member releasably coupled to a second closure member. The first closure member is positioned on a mid-portion of the first fabric portion and the second closure member is positioned on a mid-portion of the second fabric portion. A first slider is positioned on one side of the zipper closure and a second slider is positioned on an opposite side of the zipper closure. The zipper arrangement may be used to fasten and unfasten a front right garment portion and a front left garment portion by moving the sliders in opposing directions. | 10-02-2014 |
Jinseok Hwang, Palisades Park, NJ US
Patent application number | Description | Published |
---|---|---|
20130036576 | CLOSURE ARRANGEMENT WITH OPENING IN STATIONARY MEMBER - A closure arrangement comprises a first side with a first plurality of closure elements and a second side with a second plurality of closure elements. A slider is moveably positioned on the first side and an insertion pin assembly is positioned on the second side. The insertion pin assembly includes a mouth defined between an inner jaw and an outer jaw and an insertion pin positioned within the mouth. The mouth is configured to receive the slider and the insertion pin is configured for insertion into the slider. | 02-14-2013 |
Kinkai Hwang, Belle Mead, NJ US
Patent application number | Description | Published |
---|---|---|
20090088556 | FUSION ANTIGEN USED AS VACCINE AND METHOD OF MAKING THEM - Fusion antigen used as vaccine and method of making them. The method includes: (1) selecting a segment of a virus protein sequence that contains a least one epitope; (2) engineering a DNA fragment encoding the selected segment of the virus protein; (3) inserting the DNA fragment into a | 04-02-2009 |
Peter Seongwoo Hwang, Edison, NJ US
Patent application number | Description | Published |
---|---|---|
20100063297 | PROCESSES FOR THE PREPARATION OF 1,2,4-OXADIAZOLE BENZOIC ACIDS - Provided herein are processes for the preparation of compounds useful for the treatment, prevention or management of diseases associated with a nonsense mutation. More specifically, provided herein are processes for the synthesis of 1,2,4-oxadiazoles. In particular, provided herein are processes useful for the preparation of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid. | 03-11-2010 |
20100292187 | METHODS FOR TREATING HEPATITIS C - The present invention provides compounds, pharmaceutical compositions, and methods of using such compounds or compositions for treating infection by a virus, or for affecting viral IRES activity. | 11-18-2010 |
20100305100 | METHODS FOR TREATING HEPATITIS C - The present invention provides compounds, pharmaceutical compositions, and methods of using such compounds or compositions for treating infection by a virus, or for affecting viral IRES activity. | 12-02-2010 |
20110040100 | CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID - The present invention relates to crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, pharmaceutical compositions and dosage forms comprising the crystalline forms, methods of making the crystalline forms and methods for their use for the treatment, prevention or management of diseases ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay. | 02-17-2011 |
20110046136 | METHODS FOR THE PRODUCTION OF FUNCTIONAL PROTEIN FROM DNA HAVING A NONSENSE MUTATION AND THE TREATMENT OF DISORDERS ASSOCICATED THEREWITH - The present invention relates to functional proteins encoded by nucleic acid sequences comprising a nonsense mutation. The present invention also relates to methods for the production of functional proteins encoded by nucleic acid sequences comprising a nonsense mutation and the use of such proteins for prevention, management and/or treatment of diseases associated with a nonsense mutation(s) in a gene. | 02-24-2011 |
20110268698 | METHODS FOR TREATING HEPATITIS C - The present invention provides compounds, pharmaceutical compositions, and methods of using such compounds or compositions for treating infection by a virus, or for affecting viral IBES activity. | 11-03-2011 |
20120009142 | METHODS FOR TREATING HEPATITIS C - In accordance with the present invention, compounds that inhibit viral replication, preferably Hepatitis C Virus (HCV) replication, have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the treatment or prevention of a viral infection are provided. In another aspect of the invention, compounds useful in the treatment or prevention of HCV infection are provided. | 01-12-2012 |
20120087896 | HYDROXYLATED 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS, COMPOSITIONS THEREOF AND THEIR USE IN BIOASSAYS - Novel hydroxylated 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising a hydroxylated 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith. | 04-12-2012 |
20120136154 | PROCESSES FOR THE PREPARATION OF SUBSTITUTED TETRAHYDRO BETA-CARBOLINES - Provided herein are improved processes for the synthesis of substituted tetrahydro beta-carboline derivatives. In particular, provided herein are improved processes useful for the preparation of (S)-4-chlorophenyl 6-chloro-1-(4-methoxyphenyl)-3,4-dihydro-1H-pyrido[3,4- | 05-31-2012 |
20130158081 | CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID - The present invention relates to crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, pharmaceutical compositions and dosage forms comprising the crystalline forms, methods of making the crystalline forms and methods for their use for the treatment, prevention or management of diseases ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay. | 06-20-2013 |
20140235679 | CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID - The present invention relates to crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, pharmaceutical compositions and dosage forms comprising the crystalline forms, methods of making the crystalline forms and methods for their use for the treatment, prevention or management of diseases ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay. | 08-21-2014 |
Peter Seong Woo Hwang, Edison, NJ US
Patent application number | Description | Published |
---|---|---|
20120202763 | METHODS FOR TREATING CANCER AND NON-NEOPLASTIC CONDITIONS - Compounds that selectively inhibit pathological production of human vascular endothelial growth factor (VEGF) and compositions comprising such Compounds are described. Compounds that inhibit viral replication or the production of viral RNA or DNA or viral protein and compositions comprising such Compounds are described. Also described are methods of reducing VEGF using such Compounds and methods for treating cancer and non-neoplastic conditions involving the administration of such Compounds. Further described are methods of inhibiting viral replication or the production of viral RNA or DNA or viral protein using such Compounds and methods for treating viral infections involving the administration of such Compounds. The Compounds may be administered as a single agent therapy or in combination with one or more additional therapies to a human in need of such treatments. | 08-09-2012 |
Seongwoo Hwang, Edison, NJ US
Patent application number | Description | Published |
---|---|---|
20080275233 | UREIDO SUBSTITUTED BENZOIC ACID COMPOUNDS AND THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE - The invention encompasses ureido substituted benzoic acid compounds, compositions comprising the compounds and methods for treating or preventing diseases associated with nonsense mutations of mRNA by administering these compounds or compositions. | 11-06-2008 |
20100121070 | METHODS FOR THE SYNTHESIS OF 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS - Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith. | 05-13-2010 |
20100125065 | CARBOLINE DERIVATIVES USEFUL IN THE INHIBITION OF ANGIOGENESIS - In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the inhibition of VEGF production, in the inhibition of angiogenesis, and/or in the treatment of cancer, diabetic retinopathy or exudative macular degeneration are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the inhibition of angiogenesis, and/or the treatment of cancer, diabetic retinopathy or exudative macular degeneration using the compounds of the invention. | 05-20-2010 |
20100168109 | PHARMACEUTICAL COMPOSITIONS OF 1,2,4-OXADIAZOLE BENZOIC ACID AND THEIR USE FOR THE TREATMENT OF DISEASE - Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith. | 07-01-2010 |
20100179132 | CARBOLINE DERIVATIVES USEFUL IN THE INHIBITION OF ANGIOGENESIS - In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the inhibition of VEGF production, in the treatment of solid tumor cancer, and in reducing plasma and/or tumor VEGF levels, are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the treatment of cancer, and the reduction of plasma and/or tumor VEGF levels, using the compounds of the invention. | 07-15-2010 |
20100216851 | 1,2,4-OXADIAZOLE BENZOIC ACID COMPOSITIONS AND THEIR USE IN BIOASSAYS - Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith. | 08-26-2010 |
20110130391 | UREIDO SUBSTITUTED BENZOIC ACID COMPOUNDS AND THEIR USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE - The invention encompasses ureido substituted benzoic acid compounds, compositions comprising the compounds and methods for treating or preventing diseases associated with nonsense mutations of mRNA by administering these compounds or compositions. | 06-02-2011 |
20110160190 | CARBOLINE DERIVATIVES USEFUL IN THE INHIBITION OF ANGIOGENESIS - In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the inhibition of VEGF production, in the treatment of solid tumor cancer, and in reducing plasma and/or tumor VEGF levels, are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the treatment of cancer, and the reduction of plasma and/or tumor VEGF levels, using the compounds of the invention. | 06-30-2011 |
20110311486 | 1,2,4-OXADIAZOLE BENZOIC ACID COMPOSITIONS - Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith. | 12-22-2011 |
20120178080 | 1,2,4-OXADIAZOLE BENZOIC ACID COMPOSITIONS AND THEIR USE IN BIOASSAYS - Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith. | 07-12-2012 |
20120277234 | 1,2,4-OXADIAZOLE BENZOIC ACIDS - Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith. | 11-01-2012 |
20130289007 | METHODS FOR USING 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS - Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith. | 10-31-2013 |
20140301978 | METHODS FOR USING 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS - Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith. | 10-09-2014 |
20150148346 | COMPOSITIONS OF 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS AND METHODS FOR THEIR USE - Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith. | 05-28-2015 |
Young Hwang, Cherry Hill, NJ US
Patent application number | Description | Published |
---|---|---|
20150094327 | COMPOSITIONS AND METHODS FOR INHIBITING RESOLVASES - The invention provides a fluorescence polarization (FP)-based assay to identify inhibitors of resolvase's DNA cleavage activity. The invention also provides resolvase inhibitors identified by the assay, as well as derivatives and analogs thereof. In certain embodiments, the compounds of the invention are useful to treat a poxvirus infection in an infected subject. | 04-02-2015 |